SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Trimurthi Drugs & Pharmaceuticals board approves fund raising

23 Jul 2012 Evaluate
Trimurthi Drugs & Pharmaceuticals has informed that the board of directors of the company at its meeting held on July 21, 2012, has considered and approved the raising of funds by issue of convertible warrants subject to approval of shareholders in ensuing annual general meeting and after detailed discussion, recommended the dividend of 3% on the equity shares for the year 2011-12.

The above information is a part of company's filings submitted to BSE.

Novelix Pharma Share Price

56.14 -2.27 (-3.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×